SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-19-001465
Filing Date
2019-01-24
Accepted
2019-01-24 08:05:19
Documents
7
Period of Report
2019-01-23
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 79656
2 EXHIBIT 3.1 ex3_1.htm EX-3.1 4279
3 EXHIBIT 3.2 ex3_2.htm EX-3.2 3567
4 EXHIBIT 3.3 ex3_3.htm EX-3.3 100494
5 EXHIBIT 99.1 ex99_1.htm EX-99.1 17658
6 graphic1.jpg GRAPHIC 229229
7 graphic2.jpg GRAPHIC 192917
  Complete submission text file 0001140361-19-001465.txt   788932
Mailing Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130
Business Address 11975 EL CAMINO REAL, SUITE 300 SAN DIEGO, CA 92130 (858) 222-8041
APRICUS BIOSCIENCES, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22245 | Film No.: 19538644
SIC: 2834 Pharmaceutical Preparations